“The downgrade reflects our view of Stamford’s weak underlying operating performance in fiscal 2017, which was well below budget and projections provided to S&P Global Ratings at its last review, due to softer volumes than anticipated and the ongoing challenge of revenue shortfalls associated with the state’s ill-funded hospital tax program,” said Patrick Zagar, an S&P Global Ratings credit analyst.
The outlook is stable, reflecting S&P’s expectation that Stamford Hospital will see improvements in balance sheet metrics and operating performance with cost containment efforts such as a lack of additional debt plans, decreased capital spending and strategic partnerships.
More articles on healthcare finance:
Lurie Children’s Hospital receives $3.5M from Chicago Cubs first baseman
17 donations, grants to healthcare organizations in August
6 recent hospital, health system outlook and credit rating actions
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
